Zhuzhou Qianjin Pharmaceutical Co., Ltd.SSE: 600479

2025 Semi-annual Report

Aug 30, 2025 · Issued by Zhuzhou Qianjin Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Aug 30, 2025

On 6ix: 6ix.com/news/2025-semi-annual-report-98

2025 Semi-annual Report

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Zhuzhou Qianjin Pharmaceutical Co., Ltd. on 6ix

Earlier from Zhuzhou Qianjin Pharmaceutical

Announcement on the Approval by the M&A and Restructuring Review Committee of the Shanghai Stock Exchange of the Issuance of Shares and Payment of Cash to Purchase Assets through Related Party TransactionsAug 20, 2025
Announcement on the Meeting Arrangement of the Shanghai Stock Exchange M&A and Restructuring Review Committee for the Review of the Company's Proposed Issuance of Shares and Payment of Cash to Purchase Assets and Related Party TransactionsAug 13, 2025
Announcement on Amendment to Report on Purchasing Assets through Issuance of Shares and Cash Payment and Related Party Transaction (Draft) (Revised Edition)Aug 8, 2025
Announcement on Implementation of Dividend Distribution for 2024Jul 18, 2025
Announcement on Implementation of Repurchasing and Canceling Restricted StocksJul 8, 2025

Later from Zhuzhou Qianjin Pharmaceutical

Announcement on Attending 2025 Online Collective Reception Day for Investors of Listed Companies in Hunan Jurisdiction and Semi-annual Performance BriefingSep 12, 2025
Announcement on Obtaining Registration Approval from the China Securities Regulatory Commission for Issuance of Shares and Cash Payment for Asset Acquisition and Related Party TransactionsSep 13, 2025
Announcement on Amendment to Report on Purchasing Assets through Issuance of Shares and Cash Payment and Related Party TransactionSep 23, 2025
Announcement on the Implementation of Issuance of Shares and Payment in Cash for Asset Purchase and Related Party Transactions and Changes in Capital SharesOct 28, 2025
Announcement on Main Operating Data for Q3 2025Oct 30, 2025

All Zhuzhou Qianjin Pharmaceutical news releases

Follow Zhuzhou Qianjin Pharmaceutical into a list and get an email when it puts out news.

Follow Zhuzhou Qianjin Pharmaceutical